The Advertising Standards Authority (ASA) has banned a series of social media advertisements promoting prescription-only weight-loss medicines (POMs) through affiliate and referral links. The organisation notes that these rulings mark
Dr Ahmed El Muntasar presents an overview of strategies for addressing post-weight loss skin changes Significant weight loss, whether achieved through lifestyle modification, bariatric surgery or pharmacological interventions such as glucagon-like peptide-1 (GLP-1) receptor agonists, is increasingly common in clinical …
Three practitioners discuss the pathophysiology of skin laxity and evaluate treatment modalities aimed at optimising both aesthetic appearance and functional outcomes Weight loss can result from a variety of interventions. For example, lifestyle modifications including diet and exercise promote gradual, …
Aesthetics investigates the risks and repercussions of inappropriate weight-loss prescribing An ITV News investigation has revealed that young people with a healthy body mass index (BMI) are using artificial intelligence
Dr Vix Manning and Dr Charlotte Woodward examine how medically supervised FMD protocols address post-GLP-1 metabolic instability The landscape of metabolic medicine has been revolutionised by GLP-1 and GIP receptor agonists, with remarkable success in achieving rapid weight loss and …
The Advertising Standards Authority (ASA) has released rulings on multiple slimming and supplement adverts. In August, the ASA upheld five rulings against companies for making unauthorised claims involving GLP-1 production
Three practitioners share their approaches to restoring volume, supporting collagen productionand rebuilding confidence. Over the past two years, aesthetic practitioners have reported a noticeable increase in patients seeking facial rejuvenation following significant weight loss – particularly with concerns around mid-face …
The Advertising Standards Authority (ASA) has issued rulings on adverts for weight loss medication. The ASA has upheld nine complaints against online advertisers promoting weight loss injections, classified as prescription
The Medicines and Healthcare products Regulatory Agency (MHRA) has issued updated guidance for women using GLP-1 receptor agonists. Women are advised not to use these medicines during pregnancy, when trying